AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862 | +24.6% | 756 | 0.0% | 0.00% | – |
| Q2 2023 | $692 | +63.2% | 756 | 0.0% | 0.00% | – |
| Q1 2023 | $424 | -2.8% | 756 | 0.0% | 0.00% | – |
| Q4 2022 | $436 | – | 756 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 756 | -16.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 900 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $2,000 | -33.3% | 900 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | +200.0% | 900 | +81.8% | 0.00% | +100.0% |
| Q4 2020 | $1,000 | -83.3% | 495 | 0.0% | 0.00% | -83.3% |
| Q2 2020 | $6,000 | +100.0% | 495 | -42.5% | 0.01% | +200.0% |
| Q3 2019 | $3,000 | -40.0% | 861 | -7.9% | 0.00% | -33.3% |
| Q2 2019 | $5,000 | -37.5% | 935 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $8,000 | 0.0% | 935 | -2.6% | 0.01% | +50.0% |
| Q3 2018 | $8,000 | – | 960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |